About PLx Pharma
PLx Pharma is a company based in Sparta (United States) founded in 2002 by Ron Zimmerman.. PLx Pharma has raised $25.27 million across 21 funding rounds from investors including HHS and Aurus. The company has 19 employees as of December 31, 2022. PLx Pharma operates in a competitive market with competitors including Ironwood Pharma, Lyndra, RedHill Biopharma, Alcresta and Seed, among others.
- Headquarter Sparta, United States
- Employees 19 as on 31 Dec, 2022
- Founders Ron Zimmerman
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$778.66 K3793as on Dec 31, 2017
-
Net Profit
$-21.32 M-14as on Dec 31, 2016
-
EBITDA
$-21.37 M-14as on Dec 31, 2016
-
Total Equity Funding
$25.27 M (USD)
in 21 rounds
-
Latest Funding Round
$18.01 M (USD), Post-IPO
Nov 30, 2020
-
Investors
HHS
& 1 more
-
Employee Count
19
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Scientific Team
11 people
Leadership Team
5 people
Finance and Accounting
2 people
Cardiovascular Team
2 people
Unlock access to complete
Funding Insights of PLx Pharma
PLx Pharma has successfully raised a total of $25.27M across 21 strategic funding rounds. The most recent funding activity was a Post-IPO round of $18.01 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 21
- Last Round Post-IPO — $18.0M
-
First Round
First Round
(10 Jul 2008)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Post-IPO - PLx Pharma | Valuation |
investors |
|
| May, 2020 | Amount | Post-IPO - PLx Pharma | Valuation |
investors |
|
| Feb, 2019 | Amount | Post-IPO - PLx Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PLx Pharma
PLx Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and Aurus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PLx Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PLx Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Plx Pharma Comparisons
Competitors of PLx Pharma
PLx Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Lyndra, RedHill Biopharma, Alcresta and Seed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Innovates long-acting oral therapies to simplify patient medication regimens.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| domain | founded_year | HQ Location |
Synbiotics are developed for simulating the gut microbiome.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Plx Pharma
Frequently Asked Questions about PLx Pharma
When was PLx Pharma founded?
PLx Pharma was founded in 2002 and raised its 1st funding round 6 years after it was founded.
Where is PLx Pharma located?
PLx Pharma is headquartered in Sparta, United States.
Who is the current CEO of PLx Pharma?
Natasha Giordano is the current CEO of PLx Pharma.
Is PLx Pharma a funded company?
PLx Pharma is a funded company, having raised a total of $25.27M across 21 funding rounds to date. The company's 1st funding round was a Post-IPO of $15M, raised on Jul 10, 2008.
How many employees does PLx Pharma have?
As of Dec 31, 2022, the latest employee count at PLx Pharma is 19.
What is the annual revenue of PLx Pharma?
Annual revenue of PLx Pharma is $778.66K as on Dec 31, 2017.
What does PLx Pharma do?
PLx Pharma was founded in 2002 in Sparta, United States, within the pharmaceutical sector. A patent-protected PLxGuard platform is utilized to target active ingredients to specific GI tract areas, supporting nonsteroidal anti-inflammatory and over-the-counter drugs. Operations focus on gastrointestinal treatments, including the development of Vazalore as a liquid-filled aspirin capsule for pain management. The companys domain is plxpharma.com.
Who are the top competitors of PLx Pharma?
PLx Pharma's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
Who are PLx Pharma's investors?
PLx Pharma has 2 investors. Key investors include HHS, and Aurus.